Overview

Role of CYP2B6, CYP3A4, and MDR1 in the Metabolic Clearance of Methadone

Status:
Unknown status
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine to what extent CYP2B6, CYP3A4, and MDR1 polymorphisms affect the metabolism of methadone.
Phase:
Phase 1
Details
Lead Sponsor:
University of Washington
Treatments:
Bupropion
Digoxin
Methadone
Midazolam